Both standard IFN-α and Peg-IFN-α lead to frequent and sometimes severe adverse reactions, such as flu-like symptoms, asthenia, weight loss, alopecia, thrombocytopenia, and leukopenia (Abbas et al., 2011; Wedemeyer et al., 2011). The gene discussed is IFNA1; the disease is Thrombocytopenia.